The regeneration of the spinal cord activated by stabilizing, improving the provision of a scar-degrading enzyme

Researchers have developed an improved version of an enzyme that degrades the dense scar tissue that forms when the central nervous system is damaged. In digesting the tissue blocks renewed growth of damaged nerves, the enzyme improved - and the new system for the provision of information - could be used for the recovery of serious injury to the central nervous system. The enzyme, chrondroitinase ABC (chABC), it must be delivered to the damaged area for at least two weeks after the injury completely broken scar tissue. However, the enzyme works poorly at body temperature and is, therefore, be repeated injected or infused into the body.

In Book 2 published in November to the first edition of the journal Proceedings of the National Academy of Sciences, researchers describe how they have eliminated the thermal sensitivity of chABC and developed a delivery system has determined that the enzyme remains active after week without allowing an implanted catheter and pump. work was supported by National Institutes of Health.

"This research has taken digest scar clinically viable by eliminating the need for continuous injection of chABC by the thermal stabilization of the enzyme and the use of biotechnology-based drug delivery systems," the newspaper said the lead author Ravi Bellamkonda, Professor Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.

A physiological body temperature, an enzyme chABC loses half of the enzyme activity within the hour and the other functions within three to five days. For enzymes, Bellamkonda, thermostabilize Cell Biology, Emory University Associate Professor Robert McKeon and Georgia Tech student, Hyun-Jung Lee of the enzyme mixed with the sugar trehalose. The result - the activity of the enzyme was at the body temperature of up to four weeks, then stabilized in vitro tests.

The researchers used a lipid Microtube scaffolding system hydrogel thermostabilized enzymes in animals with a single injection to deliver. The framework provides sustained delivery of the enzyme for two weeks with the vials allows slow release of the tubes and the hydrogel localization of the lesion. This delivery system also allows the enzyme to diffuse deep into the tissue as catheter delivery.

In animal studies, the enzyme capable of digesting the scar two weeks after the injury and remained well preserved scar was reduced in the injury site for at least six weeks. The researchers also observed an increase in axonal sprouting and recovery of nerve function on the site of injury when the enzyme was made thermostabilized.

The administration system has also enabled the combination of therapies. Animals treated with chABC thermostabilized in combination with the continued delivery of neurotrophin-3 - a growth factor protein that helps the survival and differentiation of nerve cells support - showed a significant improvement in motor function and enhanced growth of sensory axons and sprouting of fibers for serotonin, a neurotransmitter.

"These results bring us one step closer to repairing damaged spinal cords, nerve growth in the number of steps, including minimizing the extent of secondary damage, reduction injury, inhibition by overcoming stigma and promoting, "said Bellamkonda, who was also Deputy Director of Research for GTEC, a center for regenerative medicine at the Georgia Tech and Emory University, and a Georgia Cancer Coalition Distinguished Cancer Scholar.